In The Lever, NBCC President Fran Visco emphasized one of NBCC’s key public policy priorities: that the Food and Drug Administration (FDA) should approve evidence-based drugs with clinically meaningful benefits for patients. 

Rates of lobular breast cancer are increasing among both younger and older women—a pattern not seen with other types of breast cancer. What does the research tell us about these concerning trends? 

Gain expert knowledge, engage in dynamic discussions, and forge valuable partnerships that will empower you to make a lasting impact in the fight against breast cancer. Join us in DC at NBCC’s Advocate Leadership Summit from April 25-27, followed by Lobby Day on Capitol Hill on April 28.

NBCC’s Melanie Wyne testified at the Democratic Women’s Caucus Shadow Field Hearing on threats to federally funded science and research: "I urge you to stand with millions of breast cancer advocates and demand that Congress oppose science and research cuts."

Build a foundation of scientific knowledge upon which you can strengthen and empower yourself as an activist. Apply to attend Project LEAD, NBCC’s premier science training program for breast cancer advocates.

Sharing wonderful news before the holiday rush begins: the Joyce and Irving Goldman Family Foundation has pledged to match gifts to close out the year, doubling donations made to NBCC before December 31. Your gift fuels NBCC's fight to end breast cancer through research, advocacy, and bold action that holds leaders accountable. Let's begin the holiday season with hope, determination, and twice the impact. Give now. 

All gifts made to NBCC's 501(c)3 are tax-deductible to the extent permitted by federal law minus event goods or services received. Financial information about NBCC can be obtained by contacting us at 2001 L Street, NW, Suite 500 PMB #50111, Washington, DC 20036, or by calling 800-622-2838.